Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Sabine, Wege"'
Autor:
Sivagurunathan Sutharsan, Stefanie Dillenhoefer, Matthias Welsner, Florian Stehling, Folke Brinkmann, Manuel Burkhart, Helmut Ellemunter, Anna-Maria Dittrich, Christina Smaczny, Olaf Eickmeier, Matthias Kappler, Carsten Schwarz, Sarah Sieber, Susanne Naehrig, Lutz Naehrlich, Klaus Tenbrock, Claus Pfannenstiel, Dirk Steffen, Jochen Meister, Britta Welzenbach, Anette Scharschinger, Markus Kratz, Maike Pincus, Tobias Tenenbaum, Mirjam Stahl, Kerstin Landwehr, Stefanie Dillenhöfer, Hans Kössel, Petra Kaiser, Manfred Käding, Simone Stolz, Stefan Blaas, Jutta Hammermann, Monika Gappa, Antje Schuster, Dana Spittel, Sabine Zirlik, Sabina Schmitt, Joachim Bargon, Malte Cremer, Sebastian Fähndrich, Andrea Heinzmann, Lutz Nährlich, Stefan Kuhnert, Sebastian Schmidt, Bettina Wollschläger, Anna Nolde, Inka Held, Wolfgang Kamin, Felix C. Ringshausen, Sabine Wege, Olaf Sommerburg, Norbert Geier, Sara Lisa Fleser, Heinrike Wilkens, Michael Lorenz, Paul Vöhringer, Martin Schebek, Christian Timke, Ingrid Bobis, Thomas Nüßlein, Doris Dieninghoff, Ernst Rietschel, Bastian Klinkhammer, Freerk Prenzel, Alexandra Wald, Axel Kempa, Eva Lücke, Ines Adams, Krystyna Poplawska, Simone Lehmkühler, Monika Bauck, Anne Pfülb, Rainald Fischer, Gudrun Schopper, Susanne Nährig, Matthias Griese, Jörg Grosse, Peter Küster, Birte KinderHolger Köster, Susanne Büsing, Margarethe Pohl, Andreas Artlich, Alexander Kiefer, Manfred Ballmann, Nikola Gjorgjevski, Markus A. Rose, Friederike Ruf, Rolf Mahlberg, Wolfgang Thomas, Ute Graepler, Sebastian Bode, hilipp Meyn, Josef Rosenecker, Cordula Koerner, Klaus-Michael Keller, Tina Teßmer, Helge Hebestreit, Gerhild Lohse
Publikováno v:
The Lancet Regional Health. Europe, Vol 32, Iss , Pp 100690- (2023)
Summary: Background: Treatment with elexacaftor/tezacaftor/ivacaftor (ETI) improves multiple clinical outcomes in people with cystic fibrosis (pwCF) with at least one F508del allele. This study evaluated the real-world impact of ETI on lung function,
Externí odkaz:
https://doaj.org/article/cb7f1132ad9145b4909f1a838def4b95
Autor:
Patricia Leutz-Schmidt, Daiva-Elzbieta Optazaite, Olaf Sommerburg, Monika Eichinger, Sabine Wege, Eva Steinke, Simon Y. Graeber, Michael U. Puderbach, Jens-Peter Schenk, Abdulsattar Alrajab, Simon M.F. Triphan, Hans-Ulrich Kauczor, Mirjam Stahl, Marcus A. Mall, Mark O. Wielpütz
Publikováno v:
ERJ Open Research, Vol 9, Iss 2 (2023)
Background Bronchial artery dilatation (BAD) is associated with haemoptysis in advanced cystic fibrosis (CF) lung disease. Our aim was to evaluate BAD onset and its association with disease severity by magnetic resonance imaging (MRI). Methods 188 CF
Externí odkaz:
https://doaj.org/article/88967b4379074ce3884f0c3d5830b010
Autor:
Marilisa Konietzke, Simon M. F. Triphan, Monika Eichinger, Sebastian Bossert, Hartmut Heller, Sabine Wege, Ralf Eberhardt, Michael U. Puderbach, Hans-Ulrich Kauczor, Gudula Heußel, Claus P. Heußel, Frank Risse, Mark O. Wielpütz
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundDynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) allows the assessment of pulmonary perfusion, which may play a key role in the development of muco-obstructive lung disease. One problem with quantifying pulmonary perfusion is
Externí odkaz:
https://doaj.org/article/1ca8b4993189489d94245dcd273b73f9
Autor:
Dario L. Frey, Calum Bridson, Susanne Dittrich, Simon Y. Graeber, Mirjam Stahl, Sabine Wege, Felix Herth, Olaf Sommerburg, Carsten Schultz, Alexander Dalpke, Marcus A. Mall, Sébastien Boutin
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Airway inflammation and microbiome dysbiosis are hallmarks of cystic fibrosis (CF) lung disease. However, longitudinal studies are needed to decipher which factors contribute to the long-term evolution of these key features of CF. We therefore evalua
Externí odkaz:
https://doaj.org/article/65502817e3db49e7af9bc03cefffacf8
Autor:
Lena Wucherpfennig, Simon M.F. Triphan, Sabine Wege, Hans-Ulrich Kauczor, Claus P. Heussel, Niclas Schmitt, Felix Wuennemann, Victoria L. Mayer, Olaf Sommerburg, Marcus A. Mall, Monika Eichinger, Mark O. Wielpütz
Publikováno v:
Journal of Cystic Fibrosis. 21:1053-1060
Therapy with Elexacaftor/Tezacaftor/Ivacaftor (ETI) was recently approved for adult cystic fibrosis (CF) patients with at least one F508del mutation. However, its effects on structural and functional lung abnormalities and chronic rhinosinusitis have
Autor:
Nikolaus, Kneidinger, Matthias, Hecker, Vasiliki, Bessa, Ina, Hettich, Alexandra, Wald, Sabine, Wege, Anna-Barbara, Nolde, Maike, Oldigs, Zulfiya, Syunyaeva, Heinrike, Wilkens, Jens, Gottlieb
Purpose Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is currently the major threat for immunocompromised individuals. The course of COVID-19 in lung transplant recipients in the Omicr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68137f4fef568d961bc77749c3f84aac
https://www.ncbi.nlm.nih.gov/pubmed/36083405
https://www.ncbi.nlm.nih.gov/pubmed/36083405
Autor:
Lena Wucherpfennig, Simon MF Triphan, Oliver Weinheimer, Monika Eichinger, Sabine Wege, Ralf Eberhardt, Michael U Puderbach, Hans-Ulrich Kauczor, Claus P Heussel, Gudula Heussel, Mark O Wielpütz
Background Recent studies support magnetic resonance angiography (MRA) as a diagnostic tool for pulmonary arterial disease. Purpose To determine MRA image quality and reproducibility, and the dependence of MRA image quality and reproducibility on dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c2c1ed48cfd47c05bddd7bd66455d24
Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis
Autor:
Mirjam Stahl, Simon Y. Graeber, Alexander H. Dalpke, Carsten Schultz, Dario L. Frey, Olaf Sommerburg, Sabine Wege, Marcus A. Mall, Susanne A. Dittrich, Felix J.F. Herth, Sébastien Boutin
Publikováno v:
Journal of Cystic Fibrosis. 20:754-760
Airway dysbiosis has been associated with lung disease severity in patients with cystic fibrosis (CF). However, the relationship between dysbiosis, airway inflammation and lung function impairement remains poorly understood. The aim of this study was
Autor:
Michael Puderbach, Ralf Eberhardt, Frank Risse, Gudula Heußel, Mark O. Wielpütz, Claus Peter Heußel, Marcus A. Mall, Sabine Wege, Monika Eichinger, Hans-Ulrich Kauczor
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 200:103-107
Autor:
Marcus A. Mall, Mark O. Wielpütz, Hans-Ulrich Kauczor, Alexander H. Dalpke, Simon Y. Graeber, Olaf Sommerburg, Cornelia Joachim, Mirjam Stahl, Dario L. Frey, Sébastien Boutin, Sabine Wege
Publikováno v:
Annals of the American Thoracic Society. 18(6)
Rationale: Previous studies showed that lumacaftor–ivacaftor therapy results in partial rescue of CFTR (cystic fibrosis [CF] transmembrane conductance regulator) activity and a moderate improvement...